<?xml version="1.0" encoding="UTF-8"?>
<ref id="B31">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lun</surname>
    <given-names>J. H.</given-names>
   </name>
   <name>
    <surname>Hewitt</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Yan</surname>
    <given-names>G. J. H.</given-names>
   </name>
   <name>
    <surname>Enosi Tuipulotu</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Rawlinson</surname>
    <given-names>W. D.</given-names>
   </name>
   <name>
    <surname>White</surname>
    <given-names>P. A.</given-names>
   </name>
  </person-group> (
  <year>2018</year>). 
  <article-title>Recombinant GII.
   <italic>P16</italic>/GII.4 Sydney 2012 was the dominant norovirus identified in Australia and New Zealand in 2017.
  </article-title>
  <source>
   <italic>Viruses</italic>
  </source>
  <volume>10</volume>:
  <issue>E548</issue>. 
  <pub-id pub-id-type="doi">10.3390/v10100548</pub-id>
  <?supplied-pmid 30304780?>
  <pub-id pub-id-type="pmid">30304780</pub-id>
 </mixed-citation>
</ref>
